Literature DB >> 14508407

Specificity of functional mobility measures in older adults after hip fracture: a pilot study.

Marissa E Mendelsohn1, Daniel S Leidl, Tom J Overend, Robert J Petrella.   

Abstract

OBJECTIVE: To determine the relationships between measures of functional mobility (Timed Up and Go [TUG], Self-Paced Walking [SPW], Berg Balance Scale [BBS]) and global functional status (FIM trade mark instrument), the motor component of the FIM instrument (motor FIM), and the mobility/locomotor-specific FIM component (ML-FIM) in older patients admitted to an inpatient rehabilitation program after hip fracture.
DESIGN: The TUG, SPW, BBS, and FIM instrument were administered within 24 hr after admission and before discharge to 20 patients undergoing inpatient rehabilitation after a hip fracture.
RESULTS: Significant correlations at admission were found between FIM and TUG scores (r = -0.47; p < 0.05), TUG and motor FIM (r = -0.45; p < 0.05), TUG and ML-FIM (r = -0.58; p < 0.01), FIM and BBS (r = 0.60; p < 0.01), motor FIM and BBS (r = 0.50; p < 0.05), and ML-FIM and BBS (r = 0.45; p < 0.05). At discharge, a significant correlation was found between the motor FIM and SPW (r = -0.49; p < 0.05). Change scores between both the motor FIM and ML-FIM and TUG scores were significantly correlated (r = -0.47, p < 0.05, r = -0.50, p < 0.05, respectively).
CONCLUSIONS: The FIM instrument, motor FIM, and ML-FIM may not be specific measures of functional mobility in patients with hip fracture.

Entities:  

Mesh:

Year:  2003        PMID: 14508407     DOI: 10.1097/00002060-200310000-00005

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  8 in total

Review 1.  Patient-reported outcome measures in older people with hip fracture: a systematic review of quality and acceptability.

Authors:  K L Haywood; J Brett; E Tutton; S Staniszewska
Journal:  Qual Life Res       Date:  2016-10-20       Impact factor: 4.147

2.  Effect of in-hospital comprehensive geriatric assessment (CGA) in older people with hip fracture. The protocol of the Trondheim Hip Fracture trial.

Authors:  Olav Sletvold; Jorunn L Helbostad; Pernille Thingstad; Kristin Taraldsen; Anders Prestmo; Sarah E Lamb; Arild Aamodt; Roar Johnsen; Jon Magnussen; Ingvild Saltvedt
Journal:  BMC Geriatr       Date:  2011-04-21       Impact factor: 3.921

3.  Do patients receive recommended treatment of osteoporosis following hip fracture in primary care?

Authors:  Robert J Petrella; Tim J Jones
Journal:  BMC Fam Pract       Date:  2006-05-09       Impact factor: 2.497

4.  Evaluation of Timed Up and Go Test as a tool to measure postoperative function and prediction of one year walking ability for patients with hip fracture.

Authors:  Heid Nygard; Kjell Matre; Jonas Meling Fevang
Journal:  Clin Rehabil       Date:  2015-06-24       Impact factor: 3.477

5.  Translation, reliability, agreement and validity of the Turkish version of Cumulated Ambulation Score in patients with hip fracture.

Authors:  İlker Çolak; Emel Mete; Morten Tange Kristensen; Tuğba Kuru Çolak
Journal:  Jt Dis Relat Surg       Date:  2020-06-18

6.  Psychometric Properties of the Urdu Translation of Berg Balance Scale in People with Parkinson's Disease.

Authors:  Muhammad Kashif; Ashfaq Ahmad; Muhammad Ali Mohseni Bandpei; Syed Amir Gilani; Humaira Iram; Maryam Farooq
Journal:  Int J Environ Res Public Health       Date:  2022-02-18       Impact factor: 3.390

7.  Gait outcomes of older adults receiving subacute hospital rehabilitation following orthopaedic trauma: a longitudinal cohort study.

Authors:  Saira A Mathew; Paul Varghese; Suzanne S Kuys; Kristiann C Heesch; Steven M McPhail
Journal:  BMJ Open       Date:  2017-07-20       Impact factor: 2.692

8.  Introducing a Third Timed Up & Go Test Trial Improves Performances of Hospitalized and Community-Dwelling Older Individuals.

Authors:  Mette L Bloch; Line R Jønsson; Morten T Kristensen
Journal:  J Geriatr Phys Ther       Date:  2017 Jul/Sep       Impact factor: 3.381

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.